EVGN CIK: 1574565

Evogene Ltd.

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.7
FY22:
−23.7
FY23:
−21.6
FY24:
−19.7
FY25:
−13.5
Change from FY21 to FY25
millions USD
FY21:
−20.6
FY22:
13.3
FY23:
−4.54
FY24:
9.62
FY25:
17.7
Change from FY21 to FY25
millions USD
FY21:
30.3
FY22:
9.34
FY23:
18.2
FY24:
4.66
FY25:
−6.60
millions USD
FY21:
−13.9
FY22:
−3.35
FY23:
−8.21
FY24:
−5.47
FY25:
−2.35
(positive)
Change from FY21 to FY25
millions USD
FY21:
−25.6
FY22:
−24.8
FY23:
−22.2
FY24:
−20.3
FY25:
−13.6

All amounts in millions USD Data source:SEC EDGAR